A recently published study on the prognostic impact of TP53 or DNA damage repair gene mutations concluded that TP53 mutations were an independent risk factor for PSA failure or PSA persistence and can be used to define a subgroup of patients in primary PCa (9). Here, TP53 is linked to posterior cortical atrophy.